Similar articles

• Microvolt T-wave alternans in ischemic cardiomyopathy.

  Madias JE. Madias JE. Int J Cardiol. 2013 Jan 10;162(2):135-6. doi: 10.1016/j.ijcard.2012.06.086. Epub 2012 Jul 12. Int J Cardiol. 2013. PMID: 22795709 No abstract available.
• Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial.

  Chow T, Kereiakes DJ, Onufer J, Woelfel A, Gursoy S, Peterson BJ, Brown ML, Pu W, Benditt DG; MASTER Trial Investigators. Chow T, et al. J Am Coll Cardiol. 2008 Nov 11;52(20):1607-15. doi: 10.1016/j.jacc.2008.08.018. J Am Coll Cardiol. 2008. PMID: 18992649
• Predictive significance for sudden death of microvolt-level T wave alternans in New York Heart Association class II congestive heart failure patients: a prospective study.

  Baravelli M, Salerno-Uriarte D, Guzzetti D, Rossi MC, Zoli L, Forzani T, Salerno-Uriarte JA. Baravelli M, et al. Int J Cardiol. 2005 Oct 20;105(1):53-7. doi: 10.1016/j.ijcard.2004.12.026. Int J Cardiol. 2005. PMID: 16207545
• Assessment of myocardial viability in ischemic cardiomyopathy.

  Bax JJ. Bax JJ. Heart Lung Circ. 2005;14 Suppl 2:S8-13. doi: 10.1016/j.hlc.2005.09.006. Epub 2005 Nov 7. Heart Lung Circ. 2005. PMID: 16352289 Review.
• [Ventricular tachyarrhythmia in acute and chronic myocardial ischemia: non-drug therapy and evaluation of outcome].

  Brachmann J, Schöls W, Beyer T, Hilbel T, Freigang K, Siara J, Kübler W. Brachmann J, et al. Z Kardiol. 1993;82 Suppl 5:163-6. Z Kardiol. 1993. PMID: 8154158 Review. German.